Company Filing History:
Years Active: 2013
Title: Innovations of Jing Li in Cancer Research
Introduction
Jing Li is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer research, particularly in the development of therapeutic antibodies. His work focuses on understanding and treating tumors characterized by specific cellular processes.
Latest Patents
Jing Li holds a patent for "Antibodies that bind β2." This patent encompasses compositions and methods for the classification, diagnosis, treatment, and prevention of tumors characterized by loss of REST function, expression of β2, and/or activation of Notch. The patent also includes methods for modulating cellular processes such as epithelial-mesenchymal transition (EMT), cell migration, and apoptosis. He has 1 patent to his name.
Career Highlights
Jing Li is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry.
Collaborations
Some of his notable coworkers include Jo-Anne Hongo and Victoria Smith, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Jing Li's contributions to cancer research through his innovative patents and collaborations at Genentech, Inc. highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies in oncology.